MRI-Targeted Biopsy for Prostate Cancer Reduces Risk of Overdiagnosis
Excluding systematic biopsy in favor of MRI-targeted biopsy in men with elevated prostate-specific antigen (PSA) levels reduced the probability of detecting clinically insignificant cancers, but at the risk of missing some clinically significant cancers and delaying their diagnosis, the randomized GÖTEBORG-2 trial from Sweden showed. Among nearly 18,000 participants, 0.6% of men who underwent MRI-targeted […]